Synapse - Kenneth Yu

Results (163)

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

Journal Article

Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
European Journal of Cancer (2018)

Fulltext@MSK | Save

Use of phenotypic profiling to determine sensitivity of gemcitabine with nab-paclitaxel for front-line treatment of pancreatic cancer

Meeting Abstract

Ricigliano, M.; Cooper, B.; Bartlett, A.; Yu, K. H.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Evaluation of a cell viability assay based on cultures of CTICs to identify treatment options in third-line pancreatic cancer

Meeting Abstract

Ricigliano, M.; Isacoff, W. H.; Ocean, A. J.; Cooper, B.; Welkie, M.; Bartlett, A.; Yu, K. H.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer

Meeting Abstract

Park, J. J.; Hajj, C.; Reyngold, M.; Shi, W.; Zhang, Z.; Cuaron, J. J.; Crane, C. H.; O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC)

Meeting Abstract

Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC)

Meeting Abstract

Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Early-onset pancreatic ductal adenocarcinoma (PDAC) at Memorial Sloan Kettering Cancer Center (MSKCC)

Meeting Abstract

Kunte, S.; Sangli, S.; Lemor, A.; Lowery, M. A.; Yu, K. H.; Abou-Alfa, G. K.; Varghese, A. M.; O'Reilly, E. M.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics

Meeting Abstract

Jordan, E.; Kaley, T. J.; Capanu, M.; Estrella, H.; Leach, S. D.; Basturk, O.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Yu, K. H.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Two randomized, placebo-controlled phase 3 studies of ruxolitinib (Rux) + capecitabine (C) in patients (pts) with advanced/metastatic pancreatic cancer (mPC) after failure/intolerance of first-line chemotherapy: JANUS 1 (J1) and JANUS 2 (J2)